“

The Blue Bell case demonstrates that we have better communication between federal, state and local partners when contamination does occur. In this case, South Carolina discovered the contamination through random sampling, and the genetic fingerprint was able to be matched to cases in Kansas. This enabled the FDA and states to investigate the production facilities and document contamination at the source.